Richard Evans served as a Senior Analyst covering the US pharmaceuticals industry at Sanford C. Bernstein & Co., LLC, from 1998 until 2006. He was twice ranked first amongst his peers for drug stock selection by Bloomberg Markets, and in 2006 was ranked amongst the top 20 stock pickers worldwide, also by Bloomberg Markets. Dr. Evans was named to the Institutional Investor’s All-America Research Team for much of his tenure, ranking first for major pharmaceuticals in 2006. His work has been highlighted in various major media outlets, including The Wall Street Journal, Barron’s, The New York Times, Fortune, CNN, CBS, and Frontline.
Previously, he was a member of senior management at Roche, serving most recently as vice president, Business Policy and Account Management. In this capacity, he was responsible for Roche’s commercial interactions with large organized buyers such as hospitals, hospital purchasing groups, managed-care organizations and governments. His responsibilities also included those areas of the company which define and support account interactions, namely account management, customer marketing, pricing, contract administration, pharmacoeconomics, and distribution. During his seven years at Roche, Dr. Evans also served as the head of Business Development and Strategic Planning, and as product director for the company’s injectable anesthetics. He earned a doctorate in Veterinary Medicine from North Carolina State University in 1988 and a master’s of Public and Private Management from Yale University in 1991.